loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 2333627 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 GLUCAGON (RECOMBINANT DNA ORIGIN) (GLUCAGON HYDROCHLORIDE) (1)

filter

01 NOVO NORDISK CANADA INC (1)

filter

01 KIT (1)

filter

01 1MG/VIAL (1)

filter

01 Canada (1)

URL Supplier Web Content
KIT
1MG/VIAL
GLUCAGEN HYPOKIT
Canada
2333627
1ML
Schedule D
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2333627

Looking for CTD TGA MCC DOSSIER APPLICATION 2333627 1

19

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is GLUCAGON (RECOMBINANT DNA ORIGIN) (GLUCAGON HYDROCHLORIDE), with a corresponding application number 2333627 and regulatory information .

proudly manufactured in the

Novo Nordisk's GLUCAGEN HYPOKIT KIT, medication with 1MG/VIAL of GLUCAGON (RECOMBINANT DNA ORIGIN) (GLUCAGON HYDROCHLORIDE).

Post Enquiry
POST ENQUIRY